Previous 10 | Next 10 |
Capricor Therapeutics (NASDAQ: CAPR ) -32% . More news on: Capricor Therapeutics, Inc., The Cheesecake Factory Incorporated, Astrotech Corporation, Stocks on the move, , Read more ...
Invitae 's (NYSE: NVTA) shares soared 20.5% on Wednesday as bargain-hunters and short covering converged to send the iShares Russell 2000 Index ETF (NYSEMKT: IWM) index 1.9% higher today. Global stock markets have tumbled on fear that social distancing and sheltering in place i...
SAN FRANCISCO , March 23, 2020 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company today announced its partnership with the Muscular Dystrophy Association (MDA) to offer sponsored, no-charge genetic testing to patients through the Detect Muscular Dystro...
By Daniel Shvartsman Listen to or subscribe to The Investing Edge on these podcast platforms: Apple Podcasts Spotify Google Play Stitcher Seeking Alpha As the coronavirus bear market continues to roil investors, it felt like an opportune time for ...
Investors continue to assess the economic fallout from the coronavirus pandemic. As the stock market whips around in search of a bottom, genetic testing stocks are being tossed around -- partly due to broader economic concerns, and partly due to concerns that genetic testing services are likely ...
Investors have been grappling with the coronavirus pandemic for a few weeks now, but new sources of uncertainty arose over the weekend. Increasingly restrictive measures are being taken by local, state, and federal authorities in the United States and Europe in an attempt to contain outbreaks. M...
Shares of Invitae (NYSE: NVTA) fell as much as 22% today after tumbling by double digits yesterday. The genetic testing company announced three acquisitions yesterday that will be funded with a combination of cash and stock, but the combined transactions total $195 million. By contras...
Shares of Invitae (NYSE: NVTA) closed down 11.3% today as the broader market continued to fall. Investors are coming to grips that efforts to contain regional coronavirus outbreaks -- in fact, the novel coronavirus was just declared a global pandemic -- will have a significant negative impac...
SAN FRANCISCO , March 10, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced it has entered into definitive agreements to acquire YouScript, a privately held clinical decision support and analytics platform, and Genelex, ...
SAN FRANCISCO , March 10, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, announced today the acquisition of Diploid, a privately held Belgian company that developed Moon, artificial intelligence (A.I.) software capable of diagno...
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...